Screener
Apogee Therapeutics, Inc. APGE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | MARCH 31,2026 | DECEMBER 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $451,797 | $131,549 |
| Marketable securities | 608,088 | 598,643 |
| Prepaid expenses and other current assets | 13,912 | 11,166 |
| Total current assets | 1,073,797 | 741,358 |
| Long-term marketable securities | 198,354 | 172,730 |
| Property and equipment, net | 5,280 | 5,688 |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s short-term investments?
- Apogee Therapeutics, Inc. (APGE) reported short-term investments of $608.09M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s short-term investments changed year-over-year?
- Apogee Therapeutics, Inc.'s short-term investments increased by 49.6% year-over-year, from $406.41M to $608.09M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s short-term investments?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s short-term investments has grown at a 47.0% compound annual growth rate (CAGR), from $277.14M to $598.64M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Apogee Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude